Cargando…
MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues
PURPOSE: Cisplatin (DDP) based chemotherapy regimens are widely used in advanced gastric cancer (GC). Drug resistance often limited the clinical benefits of cisplatin regimen. The mechanisms of cisplatin resistance have not been fully revealed. Therefore, further exploration of the relevant molecula...
Autores principales: | Lu, Li, Wu, Menglin, Lu, Yaoheng, Zhao, Zhicheng, Liu, Tong, Fu, Weihua, Li, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756437/ https://www.ncbi.nlm.nih.gov/pubmed/31571913 http://dx.doi.org/10.2147/OTT.S208275 |
Ejemplares similares
-
Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis
por: Lu, Li, et al.
Publicado: (2016) -
Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016) -
Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification
por: Jiang, Xuping, et al.
Publicado: (2021) -
miR-424-3p Contributes to the Malignant Progression and Chemoresistance of Gastric Cancer
por: Li, Yongyuan, et al.
Publicado: (2020) -
CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis
por: Lu, Li, et al.
Publicado: (2016)